EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 24 June 2026. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 5.30 for July-September 2025 as against Tk. 3.77 for July-September 2024. Consolidated NOCFPS was Tk. 6.14 for July-September 2025 as against Tk. 3.80 for July-September 2024. Consolidated NAV per share was Tk. 124.34 as on September 30, 2025 and Tk. 111.25 as on September 30, 2024. Reasons for significant deviations: The notable growth in net revenue during the reporting quarter compared to the corresponding prior period, (cont.1)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6a3b51cc00e9a19e44f8efc3
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.